Skip to main content
. 2022 Feb 18;9:822429. doi: 10.3389/fnut.2022.822429

Figure 3.

Figure 3

Effects of SCE on intestinal microbe composition and SCFAs in an in vitro gastrointestinal simulation system. (A) Process of in vitro gastrointestinal simulation system and group information. (B) Relative abundance of microbiota at family and genus levels. (C) Relative abundance of SCFA producers. (D) SCFA content. (B–D) Groups with “0” at the end represents samples before administration with SCE, groups with “1” at the end represents samples after administration.